Catalyst Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€132.08M - Cost of goods sold
€4.16M - Gross profit
€127.92M - SG&A expenses
€92.43M - R&D expenses
€24.69M - EBITDA
€19.20M - D&A
€8.19M - EBIT
€4.85M - Interest expenses
€924.44K - EBT
€11.86M - Tax expenses
-€6.30M - Net income
€18.16M
Cash flow statement
- Net deferred tax
€304.99K - Non-cash items
€2.70B - Changes in working capital
€12.00M - Operating cash flow
€4.38B - Capex
€2.82M - Other investing cash flow
-€25.60M - Net investing cash flow
-€22.96M - Total cash dividends paid
-€11.00M - Issuance of common stock
€298.96K - Debt repayment
€0.00 - Other financing cash flow
€150.17M - Net financing cash flow
€139.47M - Foreign exchange effects
-€3.37M - Net change in cash
-€4.69B - Cash at end of period
€131.60M - Free cash flow
€4.39B
Balance sheet
- Cash and cash equivalents
€131.51M - Cash and short-term investments
€131.51M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.36M - Total current assets
€132.87M - Property, plant & equipment
€1.55M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€1.21M - Total non-current assets
€2.76M - Total assets
€135.64M - Accounts payable
€1.42M - Short-term debt
€181.79K - Other current liabilities
€12.83M - Total current liabilities
€14.43M - Long-term debt
€1.23M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.23M - Total liabilities
€15.66M - Common stock
€12.06K - Retained earnings
-€47.22M - Other equity
€0.00 - Total equity
€119.97M - Total liabilities and shareholders' equity
€135.64M
Company information
- Market capitalization
€272.77M - Employees
7 - Enterprise Value
€748.87M
Company ratios
- Gross margin
-
96.8% Much better than peer group: -1,125.2% - EBITDA margin
-
14.5% Much better than peer group: -18,358.0% - EBIT margin
-
3.7% Much better than peer group: -18,669.3% - EBT margin
-
9.0% Much better than peer group: -18,286.0% - Net margin
-
13.7% Much better than peer group: -18,241.9% - ROE
-
15.1% Much better than peer group: -193.8% - ROA
-
13.4% Much better than peer group: -105.2% - Asset turnover
-
97.4% Much better than peer group: 11.5% - FCF margin
-
3,317.2% Much better than peer group: -16,612.8% - FCF yield
1,606.2% - Efficiency ratio
85.5% - Net sales per employee
-
€18.87M - Net income per employee
-
€2.59M